Jeffry Tambor
Addiction Medicine · Staten Island, NYNPI 1679677892
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.
Across 279 payments — averaging $13.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$603
- Lilly USA, LLC$597
- Takeda Pharmaceuticals U.S.A., Inc.$354
- GSK$349
- Novo Nordisk$251
- Supernus Pharmaceuticals, Inc.$186
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,794100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $603 |
| Lilly USA, LLC | 47 | $597 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $354 |
| GSK | 27 | $349 |
| Novo Nordisk | 24 | $251 |
| Supernus Pharmaceuticals, Inc. | 20 | $186 |
| AstraZeneca | 10 | $180 |
| Bayer | 6 | $115 |
| Boehringer Ingelheim | 5 | $107 |
| Corium, LLC | 8 | $94 |
| Otsuka America Pharmaceutical, Inc. | 5 | $85 |
| Novartis | 4 | $80 |
| Johnson & Johnson | 4 | $61 |
| Genentech USA, Inc. | 4 | $59 |
| Gilead | 3 | $58 |
| Pfizer | 3 | $51 |
| Orexo US, Inc. | 3 | $46 |
| Amarin Pharma, Inc. | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Amgen(2 entities) | 3 | $41 |
| Eisai Inc. | 3 | $40 |
| Indivior Inc. | 2 | $35 |
| Insulet Corporation | 2 | $34 |
| Lundbeck LLC | 2 | $31 |
| Cumberland Pharmaceuticals, Inc. | 2 | $30 |
| Almatica Pharma LLC | 1 | $29 |
| Antares Pharma, Inc. | 2 | $25 |
| Sunovion Pharmaceuticals Inc. | 2 | $21 |
| Abbott | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Aytu Biopharma, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,800 in reported general payments places this provider in the 85th percentile of 125 addiction medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 24 | $239 |
| Metformin Hcl | 13 | $114 |
| Atorvastatin Calcium | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Staten Island
- Paul GazzaraStaten Island$3K
- Sarup NarianiStaten Island$693
- Edmond HakimiCalverton$125K
- Alain LitwinBronx$124K
- John MarianiNew York$38K
- Stefan KantrowitzNew York$33K
- Alejo ParelladaBrooklyn$22K
- Sean ChappinAlbany$20K
- Mohammad KabirTroy$15K
- Sonia LopezJamaica$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.